Key facts
- Manuals
- 1
- Languages
- ZH
- Last added
- 2026-11-16
Featured Mozobil manuals

Mozobil (Plerixafor) Injection Package Insert
This is the Chinese prescribing information (package insert) for Mozobil (释倍灵), plerixafor injection, supplied as 1.2 ml of a 20 mg/mL clear, colorless to pale-yellow solution. It is indicated for use with G-CSF to mobilize hematopoietic stem cells into the peripheral blood in patients with non-Hodgkin lymphoma (NHL) and multiple myeloma (MM) so that stem cells can be collected and used for autologous transplantation.
The document gives the recommended subcutaneous dose based on body weight (20 mg fixed dose or 0.24 mg/kg for patients ≤83 kg; 0.24 mg/kg for patients >83 kg, not exceeding 40 mg/day), dosing 11 hours before each collection for up to 4 consecutive days after 4 days of G-CSF, dose reduction in moderate to severe renal impairment, and notes on pediatric and elderly patients. It also lists adverse reactions from clinical trials and post-marketing reports, contraindications, and warnings including anaphylaxis, leukocytosis, thrombocytopenia, splenomegaly and spleen rupture. This manual is written in Chinese.
Covers: Drug Name · Ingredients · Description · Indications · Strength · Dosage and Administration
Latest Mozobil manuals
Mozobil (Plerixafor) Injection Package Insert
User Manual 17 pages · 559 KB · ZHChinese package insert for Mozobil (plerixafor) injection 1.2 ml:24 mg, covering indications, dosing, renal-impairment adjustments and adverse reactions.
Which document do I need?
User Manual
Day-to-day operation, settings and troubleshooting. Start here if the product is already set up.
Questions answered in Mozobil manuals
What is plerixafor injection used for?
In combination with G-CSF, it is used to mobilize hematopoietic stem cells into the peripheral blood in patients with non-Hodgkin lymphoma and multiple myeloma, so the cells can be collected and used for autologous transplantation.
What is the recommended dose of Mozobil (plerixafor)?
Patients weighing 83 kg or less receive a 20 mg fixed dose or 0.24 mg/kg; patients over 83 kg receive 0.24 mg/kg, and the dose must not exceed 40 mg per day.
